Latest Breaking News On - Oxford covishield - Page 1 : comparemela.com

URL copied Covaxin phase 3 full trial results will be made public in July.  Covaxin phase 3 full trial results will be made public in July, Bharat Biotech informed on Wendesday. Covaxin is one of the three vaccines other than Oxford s Covishield and Russia s Sputnik V, that are being administered in India. It is critical to understand and further emphasise the phase-3 data will first be submitted to Central Drugs Standard Control (CDSCO) followed by peer-reviewed journals, with a timeline of 3 months for publication, and as communicated earlier COVAXIN phase 3 results full trial data will be made public during July. Once data from the final analysis of phase III studies are available, Bharat Biotech will apply for full licensure for COVAXIN, Bharat Biotech informed ANI.

Oxford covishieldSerum institute of indiaHealth ministryImage sourceBharat biotechCentral drugs standard controlSerum instituteBharat biotechசீரம் நிறுவனம் ஆஃப் இந்தியாஆரோக்கியம் அமைச்சகம்படம் மூலபாரத் பயோடெக்மைய மருந்துகள் தரநிலை கட்டுப்பாடுசீரம் நிறுவனம்